Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Hemorrhage | 12 | 2021 | 103 | 1.820 |
Why?
|
| Subarachnoid Hemorrhage | 9 | 2021 | 38 | 1.050 |
Why?
|
| Brain Diseases | 1 | 2021 | 55 | 0.680 |
Why?
|
| Fever | 1 | 2017 | 32 | 0.510 |
Why?
|
| Hospital Mortality | 7 | 2021 | 129 | 0.460 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 6 | 2021 | 88 | 0.380 |
Why?
|
| Time Factors | 11 | 2020 | 1258 | 0.370 |
Why?
|
| Female | 22 | 2021 | 12904 | 0.330 |
Why?
|
| Humans | 31 | 2021 | 22823 | 0.330 |
Why?
|
| Drainage | 3 | 2021 | 36 | 0.330 |
Why?
|
| Brain Ischemia | 2 | 2021 | 61 | 0.320 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2019 | 94 | 0.320 |
Why?
|
| Severity of Illness Index | 4 | 2017 | 795 | 0.300 |
Why?
|
| Male | 22 | 2021 | 12400 | 0.290 |
Why?
|
| Middle Aged | 17 | 2021 | 7873 | 0.280 |
Why?
|
| Nervous System Diseases | 2 | 2020 | 99 | 0.280 |
Why?
|
| Retrospective Studies | 11 | 2021 | 2976 | 0.280 |
Why?
|
| Cerebral Infarction | 2 | 2021 | 109 | 0.280 |
Why?
|
| Risk Factors | 8 | 2021 | 1966 | 0.270 |
Why?
|
| Brain Edema | 2 | 2020 | 16 | 0.270 |
Why?
|
| Encephalocele | 2 | 2020 | 17 | 0.270 |
Why?
|
| Emergency Medical Services | 2 | 2020 | 29 | 0.260 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 2 | 2019 | 9 | 0.250 |
Why?
|
| Prospective Studies | 9 | 2021 | 1487 | 0.250 |
Why?
|
| Stroke | 3 | 2017 | 241 | 0.240 |
Why?
|
| Fibrinolytic Agents | 3 | 2017 | 57 | 0.240 |
Why?
|
| Critical Care | 3 | 2020 | 97 | 0.220 |
Why?
|
| Hydrocephalus | 2 | 2021 | 14 | 0.220 |
Why?
|
| Risk Assessment | 4 | 2021 | 546 | 0.200 |
Why?
|
| Intracranial Thrombosis | 2 | 2020 | 6 | 0.200 |
Why?
|
| Aged | 14 | 2021 | 7412 | 0.190 |
Why?
|
| Length of Stay | 3 | 2021 | 298 | 0.190 |
Why?
|
| Weather | 2 | 2019 | 13 | 0.180 |
Why?
|
| Pandemics | 2 | 2020 | 201 | 0.180 |
Why?
|
| Hospitalization | 2 | 2020 | 285 | 0.170 |
Why?
|
| Leukocytosis | 1 | 2021 | 3 | 0.170 |
Why?
|
| Cerebrum | 1 | 2021 | 6 | 0.170 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 6 | 0.170 |
Why?
|
| Brain Death | 1 | 2020 | 8 | 0.170 |
Why?
|
| Hyperglycemia | 1 | 2020 | 27 | 0.170 |
Why?
|
| Occupational Health | 1 | 2020 | 16 | 0.170 |
Why?
|
| Neurologists | 1 | 2020 | 4 | 0.170 |
Why?
|
| Apnea | 1 | 2020 | 15 | 0.170 |
Why?
|
| Health Care Rationing | 1 | 2020 | 6 | 0.170 |
Why?
|
| Prognosis | 3 | 2020 | 714 | 0.170 |
Why?
|
| Logistic Models | 3 | 2017 | 350 | 0.170 |
Why?
|
| Pregnancy | 1 | 2021 | 324 | 0.160 |
Why?
|
| Cerebral Angiography | 3 | 2021 | 29 | 0.160 |
Why?
|
| Rivaroxaban | 1 | 2020 | 5 | 0.160 |
Why?
|
| Hematoma, Subdural | 1 | 2020 | 6 | 0.160 |
Why?
|
| Hemostasis | 1 | 2020 | 11 | 0.160 |
Why?
|
| Pyridones | 1 | 2020 | 10 | 0.160 |
Why?
|
| Factor Xa Inhibitors | 1 | 2020 | 4 | 0.160 |
Why?
|
| Hemostatics | 1 | 2020 | 11 | 0.160 |
Why?
|
| Blood Glucose | 1 | 2020 | 99 | 0.160 |
Why?
|
| Electroencephalography | 1 | 2020 | 70 | 0.160 |
Why?
|
| Blood Coagulation Factors | 1 | 2020 | 19 | 0.160 |
Why?
|
| Seizures | 1 | 2020 | 62 | 0.160 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 63 | 0.160 |
Why?
|
| Neurology | 1 | 2020 | 35 | 0.160 |
Why?
|
| Vasospasm, Intracranial | 1 | 2019 | 9 | 0.160 |
Why?
|
| Endocarditis | 1 | 2019 | 10 | 0.160 |
Why?
|
| Brain Injuries | 1 | 2019 | 31 | 0.150 |
Why?
|
| Pyrazoles | 1 | 2020 | 57 | 0.150 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 137 | 0.150 |
Why?
|
| Disease Management | 1 | 2019 | 98 | 0.150 |
Why?
|
| Delirium | 1 | 2018 | 12 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 74 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 77 | 0.150 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 281 | 0.150 |
Why?
|
| Critical Illness | 1 | 2018 | 97 | 0.140 |
Why?
|
| Adult | 9 | 2021 | 6896 | 0.140 |
Why?
|
| Cerebral Ventricles | 1 | 2017 | 16 | 0.140 |
Why?
|
| Cerebral Intraventricular Hemorrhage | 1 | 2017 | 2 | 0.130 |
Why?
|
| Body Temperature Regulation | 1 | 2017 | 19 | 0.130 |
Why?
|
| Therapeutic Irrigation | 1 | 2017 | 44 | 0.130 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 123 | 0.130 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2017 | 41 | 0.130 |
Why?
|
| Sodium Chloride | 1 | 2017 | 29 | 0.130 |
Why?
|
| Cytokines | 1 | 2017 | 202 | 0.120 |
Why?
|
| Odds Ratio | 1 | 2017 | 217 | 0.120 |
Why?
|
| Chicago | 4 | 2020 | 811 | 0.110 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 3717 | 0.100 |
Why?
|
| Treatment Outcome | 5 | 2021 | 2934 | 0.100 |
Why?
|
| Troponin I | 1 | 2013 | 11 | 0.100 |
Why?
|
| Intracranial Hypertension | 1 | 2013 | 11 | 0.100 |
Why?
|
| Community Health Centers | 1 | 2012 | 11 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 858 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 438 | 0.090 |
Why?
|
| Warfarin | 1 | 2012 | 25 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 572 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2012 | 82 | 0.090 |
Why?
|
| Injections, Intra-Arterial | 1 | 2011 | 5 | 0.090 |
Why?
|
| Transportation of Patients | 1 | 2011 | 4 | 0.090 |
Why?
|
| Young Adult | 4 | 2019 | 1647 | 0.090 |
Why?
|
| Thrombolytic Therapy | 1 | 2011 | 44 | 0.080 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2010 | 10 | 0.080 |
Why?
|
| Perfusion Imaging | 1 | 2010 | 7 | 0.080 |
Why?
|
| Cerebrovascular Circulation | 1 | 2010 | 28 | 0.080 |
Why?
|
| Ischemic Attack, Transient | 1 | 2010 | 16 | 0.080 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 213 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 252 | 0.080 |
Why?
|
| Leukocyte Count | 2 | 2021 | 58 | 0.080 |
Why?
|
| Patient Discharge | 2 | 2021 | 147 | 0.080 |
Why?
|
| Brain Infarction | 1 | 2009 | 63 | 0.080 |
Why?
|
| Atmospheric Pressure | 2 | 2019 | 8 | 0.080 |
Why?
|
| Age Factors | 2 | 2020 | 633 | 0.070 |
Why?
|
| Intensive Care Units | 2 | 2020 | 234 | 0.070 |
Why?
|
| Incidence | 2 | 2019 | 624 | 0.060 |
Why?
|
| Biomarkers | 2 | 2020 | 477 | 0.060 |
Why?
|
| United States | 2 | 2020 | 1762 | 0.060 |
Why?
|
| Recovery of Function | 2 | 2020 | 242 | 0.060 |
Why?
|
| Hypertension | 2 | 2018 | 163 | 0.050 |
Why?
|
| Brain | 2 | 2021 | 1202 | 0.050 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2021 | 7 | 0.040 |
Why?
|
| Weaning | 1 | 2021 | 6 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2021 | 28 | 0.040 |
Why?
|
| Patient Admission | 1 | 2021 | 18 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 50 | 0.040 |
Why?
|
| Registries | 2 | 2012 | 173 | 0.040 |
Why?
|
| Critical Care Nursing | 1 | 2020 | 3 | 0.040 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2020 | 15 | 0.040 |
Why?
|
| Pharmacists | 1 | 2020 | 16 | 0.040 |
Why?
|
| Triage | 1 | 2020 | 18 | 0.040 |
Why?
|
| Patient Transfer | 1 | 2020 | 24 | 0.040 |
Why?
|
| Physician Assistants | 1 | 2020 | 10 | 0.040 |
Why?
|
| Self Concept | 1 | 2020 | 37 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 42 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 84 | 0.040 |
Why?
|
| Nurse Practitioners | 1 | 2020 | 33 | 0.040 |
Why?
|
| Nurses | 1 | 2020 | 41 | 0.040 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2019 | 6 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2019 | 14 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 27 | 0.040 |
Why?
|
| Syndrome | 1 | 2019 | 66 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2021 | 218 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 122 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 58 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 64 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 121 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 439 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 158 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 268 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 426 | 0.040 |
Why?
|
| Physicians | 1 | 2020 | 104 | 0.040 |
Why?
|
| Temperature | 1 | 2018 | 57 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 307 | 0.040 |
Why?
|
| Sex Factors | 1 | 2019 | 384 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2020 | 189 | 0.040 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2017 | 8 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 591 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2017 | 17 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1047 | 0.030 |
Why?
|
| Leukocytes | 1 | 2017 | 30 | 0.030 |
Why?
|
| Glucose | 1 | 2017 | 43 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 270 | 0.030 |
Why?
|
| Factor VIIa | 1 | 2012 | 8 | 0.020 |
Why?
|
| Plasma | 1 | 2012 | 13 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2012 | 17 | 0.020 |
Why?
|
| Smoking | 1 | 2012 | 158 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 375 | 0.020 |
Why?
|
| Middle Cerebral Artery | 1 | 2010 | 8 | 0.020 |
Why?
|
| Carotid Artery, Internal | 1 | 2010 | 6 | 0.020 |
Why?
|